Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

NCT04535063 is registered in ClinicalTrials.gov with Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno as lead sponsor.

NCT NCT04535063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
Lead sponsor
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Phase
Phase 3
Overall status
Completed
Start date
April 18, 2020
Completion date
February 25, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19 pneumonia